References
For some reviews, see:
1a
Heathcock CH. In Asymmetric Synthesis
Part B, Vol. 3:
Morrison JD.
Academic Press;
New York:
1984.
Chap. 2.
1b
Kim BM.
Williams SF.
Masamune S. In Comprehensive Organic Synthesis
Vol. 2:
Trost BM.
Fleming I.
Pergamon Press;
Oxford:
1991.
Chap. 1.
p.239
1c
Evans DA.
Nelson JV.
Taber TR.
Top. Stereochem.
1982,
13:
1
1d
Heathcock CH.
Science
1981,
214:
395
For recent direct catalytic asymmetric aldol reactions, see:
2a
Northrup AB.
MacMillan DWC.
J. Am. Chem. Soc.
2002,
124:
6798
2b
List B.
Lerner RA.
Barbas CF.
J. Am. Chem. Soc.
2000,
122:
2395
2c
Yoshikawa N.
Kumagai N.
Matsunaga S.
Moll G.
Oshima T.
Suzuki T.
Shibasaki M.
J. Am. Chem. Soc.
2001,
123:
2466
2d
Trost BM.
Ito H.
J. Am. Chem. Soc.
2000,
122:
12003
3
Greeves N. In Comprehensive Organic Synthesis
Vol. 7:
Trost BM.
Fleming I.
Pergamon Press;
Oxford:
1991.
p.1
4a a-Alkyl b-hydroxy sulfones: Bartoli G.
Bosco M.
Cingolani S.
Marcantoni E.
Sambri L.
J. Org. Chem.
1998,
63:
3624
4b a-Alkyl b-hydroxy esters: Marcantoni E.
Alessandrini S.
Malavolta M.
Bartoli G.
Bellucci MC.
Sambri L.
Dalpozzo R.
J. Org. Chem.
1999,
64:
1986
4c a-Alkyl b-hydroxy ketones: Bartoli G.
Bellucci MC.
Bosco M.
Dalpozzo R.
Marcantoni E.
Sambri L.
Chem.-Eur. J.
2000,
14:
2590
4d a-Alkyl b-hydroxy carbonitriles: Dalpozzo R.
Bartoli G.
Bosco M.
De Nino A.
Procopio A.
Sambri L.
Tagarelli A.
Eur. J. Org. Chem.
2001,
2971
5
Wild H.
Kant J.
Walker DG.
Ojima I.
Ternansky RJ.
Morin JM.
Georg GI.
Ravikumar VT. In The Organic Chemistry of β-lactams
Georg GI.
VCH Publishers;
New York:
1993. ; and references therein
6a
Mead KT.
Park M.
Tetrahedron Lett.
1995,
36:
1205
6b
Brown HC.
Kulkarni SV.
Racherla US.
J. Org. Chem.
1994,
59:
365
6c
Hanessian S.
Tehim A.
Chen P.
J. Org. Chem.
1993,
58:
7768
7
Oishi T.
Nakata T.
Acc. Chem. Res.
1984,
17:
338
8a For a synthesis of anti-N-mono- and non-substituted β-hydroxy amides via 2-iminooxetane, see: Barbaro G.
Battaglia A.
Giorgianni P.
J. Org. Chem.
1992,
57:
5128
8b For a recent asymmetric approach, see: Kitagawa O.
Momose S.-i.
Yamada Y.
Shiro M.
Taguchi T.
Tetrahedron Lett.
2001,
42:
4865
9
Ito Y.
Katsuki T.
Yamaguchi M.
Tetrahedron Lett.
1985,
26:
4643
10a
Fujita M.
Hiyama T.
J. Am. Chem. Soc.
1985,
107:
8294
10b
Fujita M.
Hiyama T.
J. Org. Chem.
1988,
53:
5405
For diastereoselective syntheses of N-disubstituted syn- or anti-β-hydroxy amides, see:
11a
Ganesan K.
Brown HC.
J. Org. Chem.
1994,
59:
7346
11b
Denmark SE.
Griedel BD.
Coe DM.
Schnute ME.
J. Am Chem. Soc.
1994,
116:
7026
11c
Evans DA.
Tedrow JS.
Shaw JT.
Downey CW.
J. Am Chem. Soc.
2002,
124:
392
11d
Evans DA.
Downey CW.
Hubbs JD.
J. Am Chem. Soc.
2003,
125:
8706
The syn-reduction of β-keto amides is based on the preliminary formation of a chelate complex intermediate; see:
12a
Bartoli G.
Bosco M.
Dalpozzo R.
Marcantoni E.
Massaccesi M.
Rinaldi S.
Sambri L.
Tetrahedron Lett.
2001,
42:
8811
12b
Fujita M.
Hiyama T.
J. Org. Chem.
1988,
53:
5415
12c
Taniguchi M.
Fujii H.
Oshima K.
Utimoto K.
Tetrahedron
1993,
49:
11169
13a
Chérest M.
Felkin H.
Prudent N.
Tetrahedron Lett.
1968,
2199
13b
Anh NT.
Einsenstein O.
Nouv. J. Chem.
1977,
1:
61
14a
Bürgi HB.
Dunitz JD.
Shefter EJ.
J. Am. Chem. Soc.
1973,
95:
5065
14b
Bürgi HB.
Dunitz JD.
Lehn JM.
Wipff G.
Tetrahedron
1974,
30:
1563
14c
Bürgi HB.
Lehn JM.
Wipff G.
J. Am Chem. Soc.
1974,
96:
1956
15
Bartoli G.
Bosco M.
Dalpozzo R.
Marcantoni E.
Sambri L.
Chem.-Eur. J.
1997,
3:
1941 ; for related systems, see ref. 4
16
Evans DA.
Ennis MD.
Le T.
J. Am Chem. Soc.
1984,
106:
1154
17 The use of a less hindered silylating agent results in a reduced anti-selectivity of the process. This is consistent with a Felkin-Anh model in which the presence of a bulky group on the oxygen of the intermediate 3 (Scheme 2) promotes the selective approach of the hydride anion to the b-carbonyl from the opposite side. For the importance of using bulky silylated reagents to effectively prevent chelation, see: Chen X.
Hortelano ER.
Eliel EL.
J. Am Chem. Soc.
1990,
112:
6130
18 Compound 4a was isolated by chromatography (pentane/Et2O) in 87% yield, anti/syn>99/1. 1H NMR (300 MHz, CDCl3): δ = 0.86 (d, 3 H, J
HH
= 7.2 Hz), 0.90-1.00 (m, 21 H), 2.45-2.50 (m, 1 H), 2.79 (d, 3 H, J
HH
= 4.8 Hz), 4.91 (d, 1 H, J
HH
= 7.8 Hz), 5.80 (br s, 1 H, NH), 7.20-7.35 (m, 5 H). 13C NMR (75 MHz, CDCl3): δ = 12.3 (CH), 14.1 (CH3), 17.7 (CH3), 17.8 (CH3), 26.0 (CH3), 50.5 (CH), 77.4 (CH), 126.9 (CH), 127.5 (CH), 127.8 (CH), 142.7 (C), 175.1 (C).
19 A typical case is reported: (
R
*,
S
*)-2-ethyl-3-hydroxy-
N
-methylhexanamide (
2h).
[20]
The title compound was isolated by column chromatography (CH2Cl2/EtOAc) as a white solid (mp = 135-137 °C); yield 77%; anti/syn = 99/1. 1H NMR (300 MHz, CDCl3): δ = 0.85-0.95 (m, 6 H, 2 × CH3), 1.30-1.55 (m, 4 H), 1.55-1.70 (m, 1 H, CH2), 1.70-1.85 (m, 1 H, CH2), 1.95-2.05 (m, 1 H, CH), 2.80 (d, 3 H, CH3, J
HH
= 4.8 Hz), 3.00 (bs, 1 H, OH), 3.60-3.70 (m, 1 H, CH), 6.00 (br s, 1 H, NH). 13C NMR (75 MHz, CDCl3): δ = 12.0 (CH3), 14.0 (CH3), 19.2 (CH2), 23.6 (CH2), 25.9 (CH3), 38.2 (CH2), 53.5 (CH), 71.9 (CH), 176.2 (C). Anal. Calcd for C9H19NO2: H, 11.05; C, 62.39; N, 8.08. Found: H, 11.36; C, 62.18; H, 7.90.
20 Descriptors R*, S* indicate that diastereomeric compounds are obtained as racemates. We prefer this terminology to avoid the ambiguities that could arise from syn-anti descriptors.